Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Intensive Statin in Ischemic Stroke With Intracranial Atherosclerotic Plaques
NCT03753555Phase 4Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Dec 2018
- Primary completion
- Nov 2027
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of Atorva, evolocumab, probucol in ischemic stroke, intracranial atherosclerosis (ICAD), sponsored by General Hospital of the Northern Theater Command. Started Dec 2018; status: recruiting.
02
Drugs
Atorvaevolocumabprobucol
03
Conditions
ischemic strokeintracranial atherosclerosis (ICAD)
Beyond the preview
Go deeper on NCT03753555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03753555.